Search research articles
Contact Us
Filters
Showing results (41-50 of 167) with videos related to
Page
of 17
Sort By:
International Journal of Oncology
|
November 15, 2011
Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation
Manish R Patel, Ahad A Sadiq, Joe Jay-Dixon, et al.
Clinical Lung Cancer
|
March 8, 2023
Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study
Melissa L Johnson, James Strauss, Manish R Patel, et al.
Cancer Chemotherapy and Pharmacology
|
May 7, 2016
Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors
Johanna C Bendell, Manish R Patel, Kenichiro Yoshida, et al.
ESMO Open
|
February 22, 2018
Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours
Kathleen N Moore, Todd M Bauer, Gerald S Falchook, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
March 6, 2018
Malnutrition Identified by the Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition Consensus Criteria and Other Bedside Tools Is Highly Prevalent in a Sample of Individuals Undergoing Treatment for Head and Neck Cancer
Urvashi Mulasi, David M Vock, Adam J Kuchnia, et al.
Haematologica
|
September 2, 2017
CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial
Yasuhiro Oki, Kevin R Kelly, Ian Flinn, et al.
Investigational New Drugs
|
November 9, 2017
4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma
Arpita De, Blake A Jacobson, Mark S Peterson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 7, 2007
Ras pathway activation in malignant mesothelioma
Manish R Patel, Blake A Jacobson, Arpita De, et al.
Ejhaem
|
May 19, 2023
A phase 1 first-in-human study of GS-0189, an anti-signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL)
Mayur Narkhede, Nancy L Bartlett, Sami Ibrahimi, et al.
JTO Clinical and Research Reports
|
May 8, 2025
Combination of Lurbinectedin and Osimertinib for Treatment of <i>EGFR</i>-Mutated Transformed SCLC: A Brief Report
Aditi Singh, Arthi Sridhar, Aastha Poddar, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 167) with videos related to
Sort By:
Page
of 17
International Journal of Oncology
|
November 15, 2011
Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation
Manish R Patel, Ahad A Sadiq, Joe Jay-Dixon, et al.
Clinical Lung Cancer
|
March 8, 2023
Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study
Melissa L Johnson, James Strauss, Manish R Patel, et al.
Cancer Chemotherapy and Pharmacology
|
May 7, 2016
Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors
Johanna C Bendell, Manish R Patel, Kenichiro Yoshida, et al.
ESMO Open
|
February 22, 2018
Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours
Kathleen N Moore, Todd M Bauer, Gerald S Falchook, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
March 6, 2018
Malnutrition Identified by the Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition Consensus Criteria and Other Bedside Tools Is Highly Prevalent in a Sample of Individuals Undergoing Treatment for Head and Neck Cancer
Urvashi Mulasi, David M Vock, Adam J Kuchnia, et al.
Haematologica
|
September 2, 2017
CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial
Yasuhiro Oki, Kevin R Kelly, Ian Flinn, et al.
Investigational New Drugs
|
November 9, 2017
4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma
Arpita De, Blake A Jacobson, Mark S Peterson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 7, 2007
Ras pathway activation in malignant mesothelioma
Manish R Patel, Blake A Jacobson, Arpita De, et al.
Ejhaem
|
May 19, 2023
A phase 1 first-in-human study of GS-0189, an anti-signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL)
Mayur Narkhede, Nancy L Bartlett, Sami Ibrahimi, et al.
JTO Clinical and Research Reports
|
May 8, 2025
Combination of Lurbinectedin and Osimertinib for Treatment of <i>EGFR</i>-Mutated Transformed SCLC: A Brief Report
Aditi Singh, Arthi Sridhar, Aastha Poddar, et al.
Page
of 17